Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12018107rdf:typepubmed:Citationlld:pubmed
pubmed-article:12018107lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12018107lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:12018107lifeskim:mentionsumls-concept:C1556094lld:lifeskim
pubmed-article:12018107lifeskim:mentionsumls-concept:C0681842lld:lifeskim
pubmed-article:12018107lifeskim:mentionsumls-concept:C0445204lld:lifeskim
pubmed-article:12018107lifeskim:mentionsumls-concept:C0475276lld:lifeskim
pubmed-article:12018107lifeskim:mentionsumls-concept:C0549193lld:lifeskim
pubmed-article:12018107pubmed:issue2lld:pubmed
pubmed-article:12018107pubmed:dateCreated2002-5-20lld:pubmed
pubmed-article:12018107pubmed:abstractTextSerum prostate-specific antigen (PSA) determination has led to the increased detection of nonpalpable prostate cancer (T1c cancer). Some T1c cancers are small and may pose no threat. To examine the characteristics of patients with T1c cancer in Japan, patients treated with radical prostatectomy were reviewed. To predict potentially insignificant cancer, which is a candidate for delayed treatment, patients whose biopsy specimen showed relatively favorable features were also examined.lld:pubmed
pubmed-article:12018107pubmed:languageenglld:pubmed
pubmed-article:12018107pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12018107pubmed:citationSubsetIMlld:pubmed
pubmed-article:12018107pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12018107pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12018107pubmed:statusMEDLINElld:pubmed
pubmed-article:12018107pubmed:monthAprlld:pubmed
pubmed-article:12018107pubmed:issn1341-9625lld:pubmed
pubmed-article:12018107pubmed:authorpubmed-author:FuseHidekiHlld:pubmed
pubmed-article:12018107pubmed:authorpubmed-author:NagakawaOsamu...lld:pubmed
pubmed-article:12018107pubmed:authorpubmed-author:FuruyaYuzoYlld:pubmed
pubmed-article:12018107pubmed:authorpubmed-author:MasaiMotoyuki...lld:pubmed
pubmed-article:12018107pubmed:issnTypePrintlld:pubmed
pubmed-article:12018107pubmed:volume7lld:pubmed
pubmed-article:12018107pubmed:ownerNLMlld:pubmed
pubmed-article:12018107pubmed:authorsCompleteYlld:pubmed
pubmed-article:12018107pubmed:pagination109-13lld:pubmed
pubmed-article:12018107pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12018107pubmed:meshHeadingpubmed-meshheading:12018107...lld:pubmed
pubmed-article:12018107pubmed:meshHeadingpubmed-meshheading:12018107...lld:pubmed
pubmed-article:12018107pubmed:meshHeadingpubmed-meshheading:12018107...lld:pubmed
pubmed-article:12018107pubmed:meshHeadingpubmed-meshheading:12018107...lld:pubmed
pubmed-article:12018107pubmed:meshHeadingpubmed-meshheading:12018107...lld:pubmed
pubmed-article:12018107pubmed:meshHeadingpubmed-meshheading:12018107...lld:pubmed
pubmed-article:12018107pubmed:meshHeadingpubmed-meshheading:12018107...lld:pubmed
pubmed-article:12018107pubmed:meshHeadingpubmed-meshheading:12018107...lld:pubmed
pubmed-article:12018107pubmed:meshHeadingpubmed-meshheading:12018107...lld:pubmed
pubmed-article:12018107pubmed:meshHeadingpubmed-meshheading:12018107...lld:pubmed
pubmed-article:12018107pubmed:meshHeadingpubmed-meshheading:12018107...lld:pubmed
pubmed-article:12018107pubmed:meshHeadingpubmed-meshheading:12018107...lld:pubmed
pubmed-article:12018107pubmed:year2002lld:pubmed
pubmed-article:12018107pubmed:articleTitlePreoperative parameters to predict tumor volume in Japanese patients with nonpalpable prostate cancer.lld:pubmed
pubmed-article:12018107pubmed:affiliationDepartment of Urology, Faculty of Medicine, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan. furuyayu@ms.toyama-mpu.ac.jplld:pubmed
pubmed-article:12018107pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12018107pubmed:publicationTypeComparative Studylld:pubmed